OMEROS CORP Payments to Acquire Available-for-sale Securities
OMEROS CORP (OMER) reported Payments to Acquire Available-for-sale Securities of $281.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2019-05-09
- OMEROS CORP payments to acquire available-for-sale securities for the quarter ending 2019-03-31 was $281.00K, a 4.07% increase year-over-year.
- OMEROS CORP payments to acquire available-for-sale securities for the quarter ending 2018-12-31 was $23.27M, a 10622.58% increase year-over-year.
- OMEROS CORP payments to acquire available-for-sale securities for the quarter ending 2018-09-30 was $348.00K, a 99.46% decline year-over-year.
- OMEROS CORP payments to acquire available-for-sale securities for the quarter ending 2018-06-30 was $44.90M, a 74726.67% increase year-over-year.
- OMEROS CORP payments to acquire available-for-sale securities for fiscal 2018 was $68.78M, a 5.29% increase from fiscal 2017.
- OMEROS CORP payments to acquire available-for-sale securities for fiscal 2017 was $65.33M, a 11.68% decline from fiscal 2016.
- OMEROS CORP payments to acquire available-for-sale securities for fiscal 2016 was $73.97M, a 19.40% decline from fiscal 2015.
- OMEROS CORP payments to acquire available-for-sale securities for fiscal 2015 was $91.77M, a 55.93% increase from fiscal 2014.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month | Payments to Acquire Available-for-sale Securities 204 month | Payments to Acquire Available-for-sale Securities 207 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $281.00K 10-Q · filed 2019-05-09 | $23.55M derived: sum of 2 quarters · filed 2019-05-09 | $23.90M derived: sum of 3 quarters · filed 2019-05-09 | $68.79M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-12-31 | $23.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $23.62M derived: sum of 2 quarters · filed 2019-03-01 | $68.51M derived: sum of 3 quarters · filed 2019-03-01 | $68.78M 10-K · filed 2019-03-01 | ||
| 2018-09-30 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $45.24M derived: sum of 2 quarters · filed 2018-11-08 | $45.51M 10-Q · filed 2018-11-08 | $45.73M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-06-30 | $44.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $45.17M 10-Q · filed 2018-08-09 | $45.38M derived: sum of 3 quarters · filed 2019-05-09 | $109.39M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2018-03-31 | $270.00K 10-Q · filed 2019-05-09 | $487.00K derived: sum of 2 quarters · filed 2019-05-09 | $64.49M derived: sum of 3 quarters · filed 2019-05-09 | $64.55M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $64.22M derived: sum of 2 quarters · filed 2019-03-01 | $64.28M derived: sum of 3 quarters · filed 2019-03-01 | $65.33M 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $64.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $64.07M derived: sum of 2 quarters · filed 2018-11-08 | $65.11M 10-Q · filed 2018-11-08 | $80.95M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.10M 10-Q · filed 2018-08-09 | $16.95M derived: sum of 3 quarters · filed 2019-03-01 | $54.44M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $1.04M 10-Q · filed 2018-05-10 | $16.89M derived: sum of 2 quarters · filed 2019-03-01 | $54.38M derived: sum of 3 quarters · filed 2019-03-01 | $74.99M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $53.34M derived: sum of 2 quarters · filed 2019-03-01 | $73.95M derived: sum of 3 quarters · filed 2019-03-01 | $73.97M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $37.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $58.10M derived: sum of 2 quarters · filed 2017-11-09 | $58.12M 10-Q · filed 2017-11-09 | $70.47M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $20.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $20.63M 10-Q · filed 2017-08-08 | $32.98M derived: sum of 3 quarters · filed 2018-03-01 | $32.99M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $18.00K 10-Q · filed 2017-05-10 | $12.37M derived: sum of 2 quarters · filed 2018-03-01 | $12.38M derived: sum of 3 quarters · filed 2018-03-01 | $12.39M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $12.36M derived: sum of 2 quarters · filed 2018-03-01 | $12.38M derived: sum of 3 quarters · filed 2018-03-01 | $91.77M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $27.00K derived: sum of 2 quarters · filed 2016-11-09 | $79.42M 10-Q · filed 2016-11-09 | $79.42M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $79.40M 10-Q · filed 2016-08-09 | $79.41M derived: sum of 3 quarters · filed 2017-03-16 | $79.41M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $79.39M 10-Q · filed 2016-05-10 | $79.39M derived: sum of 2 quarters · filed 2017-03-16 | $79.39M derived: sum of 3 quarters · filed 2017-03-16 | $79.40M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $5.00K derived: sum of 2 quarters · filed 2017-03-16 | $10.00K derived: sum of 3 quarters · filed 2017-03-16 | $58.85M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $8.00K derived: sum of 2 quarters · filed 2015-11-09 | $58.85M 10-Q · filed 2015-11-09 | $83.07M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $58.84M 10-Q · filed 2015-08-10 | $83.06M derived: sum of 3 quarters · filed 2016-03-15 | $86.41M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $58.84M 10-Q · filed 2015-05-11 | $83.06M derived: sum of 2 quarters · filed 2016-03-15 | $86.40M derived: sum of 3 quarters · filed 2016-03-15 | $102.57M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | $24.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $27.57M derived: sum of 2 quarters · filed 2016-03-15 | $43.73M derived: sum of 3 quarters · filed 2016-03-15 | $47.18M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $19.51M derived: sum of 2 quarters · filed 2014-11-10 | $22.96M 10-Q · filed 2014-11-10 | $33.69M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $16.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $19.62M 10-Q · filed 2014-08-11 | $30.34M derived: sum of 3 quarters · filed 2015-03-16 | $69.16M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $3.46M 10-Q · filed 2014-05-12 | $14.18M derived: sum of 2 quarters · filed 2015-03-16 | $53.00M derived: sum of 3 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $10.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $49.55M derived: sum of 2 quarters · filed 2015-03-16 | $49.55M 10-K · filed 2015-03-16 | |||
| 2012-09-30 | $38.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $38.82M 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $0.00 derived: sum of 2 quarters · filed 2014-03-13 | $0.00 derived: sum of 3 quarters · filed 2014-03-13 | $9.00M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $9.00M 10-Q · filed 2012-11-09 | $28.00M derived: sum of 4 quarters · filed 2013-03-18 | $214.87M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $9.00M 10-Q · filed 2012-08-07 | $28.00M derived: sum of 3 quarters · filed 2013-03-18 | $66.76M derived: sum of 4 quarters · filed 2013-03-18 | $214.87M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $9.00M 10-Q · filed 2012-05-10 | $28.00M derived: sum of 2 quarters · filed 2013-03-18 | $66.76M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $57.76M derived: sum of 2 quarters · filed 2013-03-18 | $57.77M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $38.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $38.77M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $5.00K 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $64.21M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |